SenzaGen Launches First In Vitro Airway Allergy Test
The test uses genetic biomarkers to determine with high accuracy whether inhaled substances and chemicals that come into contact with the lungs are allergenic or not.
Read MorePosted by Melissa Mayer | Oct 28, 2018 | Allergy & Autoimmune, Culture Media, Respiratory Disease |
The test uses genetic biomarkers to determine with high accuracy whether inhaled substances and chemicals that come into contact with the lungs are allergenic or not.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Infectious Diseases, Molecular Diagnostics, Point-of-Care |
Enables hepatitis C point-of-care molecular testing and linkage to care.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Research |
NIH small business technology transfer grant supports ‘game-changing’ epigenetic ASD diagnostic test.
Read MorePosted by Melissa Mayer | Oct 20, 2018 | Research |
Partners to conduct first study using ctDNA-based minimal residual disease assessment for immunotherapy in the adjuvant non-small cell lung cancer setting.
Read MorePosted by Melissa Mayer | Oct 20, 2018 | Controls, Hematology & Serology, Software, Transfusion & Transplantation Tests |
The molecular red blood cell typing test offers the shortest time to reportable results for US hospitals, reference labs, and blood centers.
Read More